8-K

Company

Kalaris Therapeutics, Inc.

Filed

November 3, 2025

Period of Report

October 28, 2025

Accession Number

0001193125-25-261697

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →